JBIO — Jade Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Jade Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.57	167	129	122	78.6
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.68	174	131	124	80.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.039	0.728	1.25	0.902	0.215
Other Long Term Assets
Total Assets	4.71	175	135	127	80.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.77	2.55	7.78	17.6	3.83
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.77	2.94	8.56	18	3.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2.94	172	127	109	76.4
Total Liabilities & Shareholders' Equity	4.71	175	135	127	80.3
Total Common Shares Outstanding